Helicobacter pylori eradication: Sequential therapy and Lactobacillus reuteri supplementation

Figure 1 Helicobacter pylori eradication rate in the following groups of patients. 1: 10-d sequential therapy plus Lactobacillus reuteri (L. reuteri) post therapy; 2: 10-d sequential therapy plus L. reuteri during therapy; 3: 10-d sequential therapy; 4: 7-d standard triple therapy plus L. reuteri post therapy; 5: 7-d standard triple therapy plus L. reuteri during therapy; 6: 7-d standard triple therapy. The eradication rate was significantly higher in the sequential group compared with the 7-d triple therapy group (88% vs 63%, P = 0.01). No difference was found between patients submitted to L. reuteri supplementation during or after antibiotic treatment.